Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

PRISM Protocol: a Randomised Phase II Trial of Nivolumab in Combination with Alternatively Scheduled Ipilimumab in First-Line Treatment of Patients with Advanced or Metastatic Renal Cell Carcinoma

Hannah L. Buckley,Fiona J. Collinson,Gemma Ainsworth,Heather Poad,Louise Flanagan,Eszter Katona,Helen C. Howard,Geraldine Murden,Rosamonde E. Banks,Joanne Brown,Galina Velikova,Tom Waddell,Kate Fife,Paul D. Nathan,James Larkin,Thomas Powles,Sarah R. Brown,Naveen S. Vasudev

Annals of Oncology（2018）

Cited 13|Views52
Key words
Renal cancer,Nivolumab,Ipilimumab,Schedule,Safety,Efficacy,Randomised,Immunotherapy,Trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined